Anaptysbio (ANAB) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to -$22.5 million.
- Anaptysbio's Gains from Investment Securities fell 4607.8% to -$22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.0 million, marking a year-over-year decrease of 223.44%. This contributed to the annual value of $7.5 million for FY2024, which is N/A changed from last year.
- Latest data reveals that Anaptysbio reported Gains from Investment Securities of -$22.5 million as of Q3 2025, which was down 4607.8% from -$19.6 million recorded in Q2 2025.
- Anaptysbio's Gains from Investment Securities' 5-year high stood at $40.2 million during Q4 2024, with a 5-year trough of -$24.8 million in Q2 2024.
- Its 5-year average for Gains from Investment Securities is -$2.0 million, with a median of -$4.6 million in 2022.
- Over the last 5 years, Anaptysbio's Gains from Investment Securities had its largest YoY gain of 27306.27% in 2024, and its largest YoY loss of 46847.18% in 2024.
- Quarter analysis of 5 years shows Anaptysbio's Gains from Investment Securities stood at $20.7 million in 2021, then decreased by 18.51% to $16.9 million in 2022, then fell by 22.14% to $13.1 million in 2023, then skyrocketed by 206.19% to $40.2 million in 2024, then crashed by 156.03% to -$22.5 million in 2025.
- Its Gains from Investment Securities was -$22.5 million in Q3 2025, compared to -$19.6 million in Q2 2025 and -$18.1 million in Q1 2025.